BSE - Delayed Quote INR

Camlin Fine Sciences Limited (CAMLINFINE.BO)

242.65

+10.30

+(4.43%)

At close: 3:49:55 PM GMT+5:30

Tesla EU sales, FDA & Moderna, DraftKings: Trending Tickers

Tesla (TSLA) sales were mixed in Europe during May. Its sales in Norway more than tripled, while sales in France, Sweden, Denmark, the Netherlands, and Spain declined. The US Food and Drug Administration (FDA) approved Moderna's (MRNA) new COVID-19 vaccine, sending the pharmaceutical giant's stock higher. DraftKings (DKNG) stock is under pressure following news that Two Sigma Advisers lowered its stake in the company and after Illinois lawmakers passed a sports-betting tax increase. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.

Yahoo Finance Video 9 minutes ago

TSLA

MRNA

DKNG
Google to spend $500 million revamping compliance in shareholder settlement

(Reuters) -Google agreed to spend $500 million over 10 years to overhaul its compliance structure, to settle shareholder litigation accusing the search engine company of antitrust violations, settlement papers show. The preliminary settlement of so-called derivative litigation against officials at Google parent Alphabet, including Chief Executive Sundar Pichai and Google co-founders Sergey Brin and Larry Page, was filed late Friday. The changes include creating a standalone board committee to oversee risk and compliance, previously the responsibility of the Alphabet board's audit and compliance committee.

Reuters 13 minutes ago

GOOG
Kymera Therapeutics Says Atopic Dermatitis Potential Matches Sanofi/Regeneron's Blockbuster Dupixent In Early Biomarker Response

Kymera Therapeutics, Inc. (NASDAQ:KYMR) on Monday revealed clinical results from the Phase 1 healthy volunteer study of KT-621, its first-in-class, oral STAT6 degrader medicine. The findings significantly surpassed the company’s expectations, demonstrating robust STAT6 degradation and a favorable safety profile, thereby derisking the program, the company said in a press release. Pharmacokinetics (PK): KT-621 demonstrated a favorable plasma PK profile after single and multiple doses. Rapid absorp

Benzinga 19 minutes ago

KYMR

REGN
Bristol Myers Inks $11 Billion Licensing Pact With BioNTech For Bispecific Cancer Drug

BioNTech SE (NASDAQ:BNTX) and Bristol Myers Squibb & Co. (NYSE:BMY) entered into a co-development and co-commercialization agreement. The pact focuses on BioNTech’s investigational bispecific antibody BNT327 across numerous solid tumor types. Under the agreement, BioNTech and Bristol Myers Squibb will work jointly to broaden and accelerate the development of this clinical candidate. Also Read: BioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology Expa

Benzinga 34 minutes ago

BNTX

CELG-RT
Blueprint Medicines Soars 26% on $9.5 Billion Buyout. Why This Drug Is Key to the Deal.

Blueprint Medicines Blueprint Medicines stock was soaring Monday after French drugmaker Sanofi said it had agreed to buy the biotech company for $9.5 billion. Sanofi’s American depositary receipts slipped 0.4%. Sanofi is paying $129 a share in cash at closing, and Blueprint shareholders will also receive a nontradeable contingent value right that will entitle them to payments worth up to $6 a share if certain milestones are met.

Barrons.com 58 minutes ago

BPMC

SNY
These Stocks Are Moving the Most Today: Cleveland-Cliffs, Tesla, Blueprint Medicines, Moderna, BioNTech, DraftKings, and More

Shares of steel companies soar after President Donald Trump says he will raise tariffs on imported steel to 50% from 25%.

Barrons.com 1 hour ago

STLD

MRNA

BPMC
Boeing upgraded, PayPal initiated: Wall Street's top analyst calls

Boeing upgraded, PayPal initiated: Wall Street's top analyst calls

The Fly 1 hour ago

BA

TFC

PYPL
Cleveland-Cliffs Stock, Other Steel Shares Soar on Trump’s Bombshell Steel Tariff Announcement

President Trump said tariffs on imported steel would go to 50% from 25%. That has investors excited early Monday.

Barrons.com 1 hour ago

X

STLD
Sanofi to Acquire Blueprint Medicines for up to $9.5 Billion to Expand Immunology Portfolio

Sanofi (SNY) agreed to acquire biopharmaceutical company Blueprint Medicines (BPMC) in a deal worth

PREMIUM
MT Newswires 1 hour ago

SNY

BPMC
Alphabet stock falls on monopoly case uncertainties

Investing.com -- Shares of Alphabet Inc. (NASDAQ:GOOGL) fell 2% as the outcome of a federal antitrust case remains uncertain. During a recent hearing, U.S. District Judge Amit Mehta indicated he might consider less stringent measures than those proposed by the Department of Justice (DOJ) to address Google’s dominance in online search and advertising.

Investing.com 1 hour ago

GOOG
Nucor Leads S&P 500 On Trump's 50% Steel, Aluminum Tariffs

President Donald Trump's Friday announcement that steel and aluminum tariffs will double to 50% on June 4 sent shares of U.S. producers surging early Monday, including Nucor, Cleveland-Cliffs and Century Aluminum. Trump made the announcement at a Friday rally near Pittsburgh, celebrating Nippon Steel's deal to buy U.S. Steel, which he blessed after the Japanese company pledged to build a new mill and double its spending plan. "Nobody's going to get around that," Trump said Friday, in announcing the 50% steel tariff.

Investor's Business Daily 1 hour ago

CLF

X

CENX
Broadcom (AVGO) Q2 Earnings Preview: What to Expect From Upcoming Report

Broadcom Eyes a Major Surge as Q2 Profit Forecast Ignites Investor Frenzy

GuruFocus.com 1 hour ago

AVGO

NVDA
UnitedHealth Declines 40.4% YTD: Here's Why it's Still Not a Bargain

UNH shares have plunged YTD, but regulatory risks, cost pressures and earnings downgrades keep it far from a bargain.

Zacks 1 hour ago

UNH
Alphabet Inc. (GOOGL) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Alphabet (GOOGL). This makes it worthwhile to examine what the stock has in store.

Zacks 1 hour ago

GOOG
Is Trending Stock Palantir Technologies Inc. (PLTR) a Buy Now?

Zacks.com users have recently been watching Palantir Technologies (PLTR) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks 1 hour ago

PLTR
Is UnitedHealth Group (NYSE:UNH) A Risky Investment?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Simply Wall St. 1 hour ago

UNH
Is Trending Stock Alphabet Inc. (GOOG) a Buy Now?

Zacks.com users have recently been watching Alphabet (GOOG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks 1 hour ago

GOOG
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Computer and Technology Names

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Zacks 1 hour ago

AVGO

CRM
Broadcom Announces New CloudHealth User Experience for Greater Cloud Spend Management Across Enterprise Teams

New AI-powered Features Deliver Actionable Insights and Enhanced CollaborationPALO ALTO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- Broadcom (NASDAQ: AVGO) today announced the general availability of the newest investment made to VMware Tanzu CloudHealth, a comprehensive new user experience that delivers a suite of feature enhancements and new AI-powered features like Intelligent Assist and Smart Summary. The new CloudHealth experience brings more accurate data and actionable insights to the enti

GlobeNewswire 1 hour ago

AVGO
Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover

French drugmaker Sanofi said Monday it has agreed to acquire Blueprint Medicines for up to $9.5 billion, sending shares of the Cambridge, Mass.-based biopharma firm soaring in intraday trading.

Investopedia 1 hour ago

SNY

BPMC

Performance Overview

Return	CAMLINFINE.BO	S&P BSE SENSEX (^BSESN)
YTD	+84.95%	+4.14%
1-Year	+158.55%	+10.02%
3-Year	+104.85%	+45.78%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Camlin Fine Sciences Limited (CAMLINFINE.BO)

Related News

Tesla EU sales, FDA & Moderna, DraftKings: Trending Tickers

Google to spend $500 million revamping compliance in shareholder settlement

Kymera Therapeutics Says Atopic Dermatitis Potential Matches Sanofi/Regeneron's Blockbuster Dupixent In Early Biomarker Response

Bristol Myers Inks $11 Billion Licensing Pact With BioNTech For Bispecific Cancer Drug

Blueprint Medicines Soars 26% on $9.5 Billion Buyout. Why This Drug Is Key to the Deal.

These Stocks Are Moving the Most Today: Cleveland-Cliffs, Tesla, Blueprint Medicines, Moderna, BioNTech, DraftKings, and More

Boeing upgraded, PayPal initiated: Wall Street's top analyst calls

Cleveland-Cliffs Stock, Other Steel Shares Soar on Trump’s Bombshell Steel Tariff Announcement

Sanofi to Acquire Blueprint Medicines for up to $9.5 Billion to Expand Immunology Portfolio

Alphabet stock falls on monopoly case uncertainties

Nucor Leads S&P 500 On Trump's 50% Steel, Aluminum Tariffs

Broadcom (AVGO) Q2 Earnings Preview: What to Expect From Upcoming Report

UnitedHealth Declines 40.4% YTD: Here's Why it's Still Not a Bargain

Alphabet Inc. (GOOGL) is Attracting Investor Attention: Here is What You Should Know

Is Trending Stock Palantir Technologies Inc. (PLTR) a Buy Now?

Is UnitedHealth Group (NYSE:UNH) A Risky Investment?

Is Trending Stock Alphabet Inc. (GOOG) a Buy Now?

Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Computer and Technology Names

Broadcom Announces New CloudHealth User Experience for Greater Cloud Spend Management Across Enterprise Teams

Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover

Performance Overview